By bertrand
June 16 2026 Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Cardiawave_PR_First_treatments_aortic_Stenosis_15 06 2026Download << Press Release
By bertrand
04/12/2025 VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking Cardiawave_PR CE Mark Valvosoft 2025-12-04Download << Press Release
By bertrand
04/12/2025 VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE Cardiawave_PR CE Mark Valvosoft 2025-12-04_FRDownload << Press Release
By bertrand
27/10/2025 Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA PR Cardiawave Nomme Jonathan Freeman Président du CA – 27 10 2025Download << Press Release
By bertrand
23/10/2025 Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman PR Cardiawave Appoints Jonathan Freeman as COB – 23 10 2025Download << Press Release
By bertrand
New article in Cath’Lab ! July 29th 2025 📰 We are pleased to share an article published in Cath’Lab that highlights the potential of non-invasive ultrasound therapy (NIUT) as an alternative approach for patients with symptomatic severe aortic stenosis (sSAS)who are not eligible for valve replacement procedures. The article presents the principles behind this technology developed by Cardiawave, and its … Continued
By bertrand
23/05/2025 Cardiawave annonce les résultats positifs à 12 mois de ses études “Valvosoft® FIM Study” et « Valvosoft® Pivotal Study » à l’EuroPCR! DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
23/05/2025 Cardiawave Announces Positive 12-Month Results from Its “Valvosoft® FIM Study” and “Valvosoft® Pivotal Study”, presented at EuroPCR! DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
Présentation des résultats de l’étude « Valvosoft® Pivotal Study » par le Pr Messas à l’ESC Congress 2024! 3 décembre 2024 ✅ Merci au Pr. Emmanuel Messas pour sa présentation des résultats de l’étude « Valvosoft® Pivotal Study », lors de l’ESC Congress 2024 à Londres ! 🎥 https://www.cardio-online.fr/Videos/Les-Entretiens/2024/Evaluation-chez-60-patients-du-traitement-non-invasif-par-ultrasons-de-stenoses-aortiques-serrees ESCCongress #Innovation #Santé #SténoseAortique #NIUT #ultrasonsfocalises … Continued
By bertrand
Cardiawave’s results published in Journal of Clinical Medicine! November 19th 2024 🌟@Cardiawave is proud to share a recent publication in the @Journal of Clinical Medicine that highlights our innovative technology! The first-in-human Valvosoft® FIM Study in Serbia has shown significant results for Non-Invasive Ultrasound Therapy (NIUT) as a treatment for severe symptomatic aortic stenosis in … Continued